Features Screener Stocks Charts
Sign In Sign Up

Neuland Laboratories Limited Income Statement

NSE:NEULANDLAB | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year NEULANDLAB income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 15.71B 14.97B
Cost of Revenue -5.77B -5.88B
Gross Profit 9.94B 9.10B
Sales, General & Admin -5.19B -5.66B
Operating Income 4.15B 2.78B
Profit Before Tax 4.01B 3.46B
Net Income 3.00B 2.60B
Diluted Shares 12.83M 12.83M
Diluted EPS 233.89 202.74

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025